This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shedden, K. A. Articles by Cho, K. R. Search for Related Content PubMed PubMed Citation Articles by Shedden, K. A. Articles by Cho, K. R.

Histologic Type, Organ of Origin, and Wnt Pathway Status: Effect on Gene Expression in Ovarian and Uterine Carcinomas

Departments of ¹ Statistics, ² Pathology, ³ Pediatrics, and ⁴ Internal Medicine and ⁵ Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan; ⁶ Department of Gynecology, Faculty of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan; and ⁷ Department of Pathology, Weill Medical College of Cornell University, New York, New York

Requests for reprints: Kathleen R. Cho, Department of Pathology, University of Michigan Medical School, 5401 Life Sciences Institute, 210 Washtenaw Avenue, Ann Arbor, MI 48109-2216. Phone: 734-764-1549; Fax: 734-647-7950; E-mail: kathcho{at}med.umich.edu.

Purpose: Ovarian and uterine carcinomas manifest several differentiation patterns resembling those seen in nonneoplastic epithelia of the gynecologic tract. Specific oncogene and tumor suppressor gene defects have been associated with particular differentiation patterns in carcinomas arising in either the uterus or ovary. For instance, ovarian and uterine carcinomas with endometrioid differentiation frequently show ß-catenin mutations. Whereas type of differentiation is considered in the treatment of uterine carcinomas, it does not presently contribute to decisions about treatment of ovarian carcinomas. A widely accepted view is that the accumulation of specific gene defects and gene expression changes underlies phenotypic traits of cancers, including their response to treatment.

Experimental Design: Using oligonucleotide microarrays to assess gene expression in 103 primary ovarian and uterine carcinomas, we sought to address whether organ of origin or type of differentiation (histotype; endometrioid versus serous) had a more substantial effect on gene expression patterns.

Results: We found that effects on gene expression due to organ of origin and histotype are similar in magnitude and are parallel in that organ effects are similar in the two histotypes and histotype effects are similar in the two organs. In addition, ovarian and uterine endometrioid adenocarcinomas with ß-catenin defects show a common gene expression signature largely distinct from that seen in tumors lacking such defects.

Conclusions: Our results illustrate how organ of origin, type of differentiation, and specific molecular defects all contribute to gene expression in the most common types of ovarian and uterine cancers. The findings also imply gene expression data will be of value for stratifying ovarian cancer patients for new treatment approaches.

This article has been cited by other articles:

				M. V. Iorio, R. Visone, G. Di Leva, V. Donati, F. Petrocca, P. Casalini, C. Taccioli, S. Volinia, C.-G. Liu, H. Alder, et al. MicroRNA Signatures in Human Ovarian Cancer Cancer Res., September 15, 2007; 67(18): 8699 - 8707. [Abstract] [Full Text] [PDF]

				T. R. Kumar Multiple Ovulations, Ovarian Epithelial Inclusion Cysts, and It'SMAD Two! Endocrinology, August 1, 2007; 148(8): 3591 - 3594. [Full Text] [PDF]

				K. K. Zorn, T. Bonome, L. Gangi, G. V.R. Chandramouli, C. S. Awtrey, G. J. Gardner, J. C. Barrett, J. Boyd, and M. J. Birrer Gene Expression Profiles of Serous, Endometrioid, and Clear Cell Subtypes of Ovarian and Endometrial Cancer Clin. Cancer Res., September 15, 2005; 11(18): 6422 - 6430. [Abstract] [Full Text] [PDF]